Sanofi India · NSE: SANOFI · BSE: 500674
Q3 FY20 results · Oct–Dec 2019
Sanofi India reported revenue from operations of ₹826.30 crore (up 13.8% from Q3 FY19) and net profit of ₹97.30 crore (up 22.7% from Q3 FY19) for Q3 FY20 (Oct–Dec 2019), on a standalone basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 826.30 | 726.40 | +13.8% | 779.10 | +6.1% |
| Other income | 24.80 | 20.10 | +23.4% | 22.90 | +8.3% |
| Total income | 851.10 | 746.50 | +14.0% | 802.00 | +6.1% |
| Profit before tax | 161.30 | 130.80 | +23.3% | 132.70 | +21.6% |
| Net profit for the period | 97.30 | 79.30 | +22.7% | 126.60 | −23.1% |
| EPS, basic (₹) | 42.26 | 34.48 | +22.6% | 54.96 | −23.1% |
| Net margin (%) | 11.8 | 10.9 | 16.2 |
Standalone
- Filed with BSE
- 26 Feb 2020, 16:15 IST
- Board meeting
- 25 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Audited
- Source
- XBRL filing on BSE